Gapping up
In reaction to strong earnings/guidance:
- CAMP +17.1%, BIG +10.3%, SNX +8.4%, PRGS +3.9%, MMYT +1.3%
Other news:
- VXRT +29.4% (extends big move during Thursday's session)
- ALT +25.7% (Venrock Healthcare Capital discloses 20.8% stake in ALT)
- ZGNX +16.4% (receives FDA approval for FINTEPLA)
- MNOV +13.1% (reports Positive preclinical results regarding MN-166)
- AXSM +11% (receives FDA breakthrough therapy designation for AXS-05 for the treatment of Alzheimer's disease agitation
- SITC +10.2% (to join S&P SmallCap 600)
- SPCE +5.9% (completes second SpaceShipTwo test flight from Spaceport America)
- XERS +4.4% (prices 7,400,000 shares of its common stock at $2.72 per share and $75 mln of 5.00% Convertible Senior Notes due 2025)
- PCG +2.8% (prices offering of 423,372,629 shares of its common stock at $9.50 per share and its previously announced concurrent underwritten public offering of 14,545,455 of its equity units at a price of $100 per unit)
Analyst comments:
- FTCH +3.1% (upgraded to Buy from Neutral at BTIG Research)
- DKNG +3.1% (initiated with a Buy at Rosenblatt)
- NTAP +3% (upgraded to Buy from Neutral at BofA/Merrill)
- EBAY +2.6% (upgraded to Buy from Hold at Deutsche Bank)
- AVGO +2.1% (upgraded to Outperform from In-line at Evercore ISI)
- IZEA +1.6% (upgraded to Buy from Neutral at Ladenburg Thalmann)
- AMZN +0.7% (target raised to Street-high $3333 from $2750 at Deutsche Bank)